Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RARE
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
RARE
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

RARE Similar Chart Price Prediction

The price of RARE is predicted to go up 10.36%, based on the high correlation periods with ABG. The similarity of these two price pattern on the periods is 90.06%.

stocks logo

RARE

stocks logo

ABG

Up: 10.36%Similarity: 90.06%

RARE Revenue Forecast

RARE EPS Forecast

RARE FAQs

What is bull’s view on RARE?

RARE stock has a bullish outlook with a price target of $140 by Piper Sandler, reflecting a 224.37% upside due to strong clinical pipeline progress and revenue growth projections. Cantor Fitzgerald also reiterates a Buy rating with a $118 target, citing robust product performance and strategic advancements. HC Wainwright supports a Strong Buy with a $95 target, emphasizing the company's leadership in rare disease treatments.

What is bear's view on RARE?

RARE stock closed at $43.03 on January 31, 2025, down 0.85% for the day. Analysts maintain a bullish view, with Morgan Stanley and J.P. Morgan setting price targets of $64 and $102, respectively, citing strong revenue growth projections for 2024-2025 and promising clinical trial advancements. The current price appears undervalued relative to its potential, supported by robust fundamentals and pipeline progress.

What is RARE revenue forecast for next quarter？

The market consensus for RARE's revenue in the upcoming quarter is projected to be approximately $145.98M USD.

RARE VS S&P500

Ask Intellectia about RARE

RARE Analyst's Forecast

Anupam Rama

JP Morgan

Buy

2024-11-21

Price Target

$105 → $102

Upside

+115.37%

JPMorgan lowered the firm's price target on Ultragenyx to $102 from $105 and keeps an Overweight rating on the shares. The firm updated models in the smid-cap biotechnology space.
Whitney Ijem

Canaccord Genuity

Strong Buy

2024-11-06

Price Target

$109 → $121

Upside

+139.51%

Yaron Werber

TD Cowen

Strong Buy

2024-10-21

Price Target

$61 → $73

Upside

+34.04%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

KMPR

Kemper Corp

$65.08
-1.05%
stocks logo

GVA

Granite Construction Inc

$82.71
0.99%
stocks logo

KGS

Kodiak Gas Services Inc

$42.9
2.07%
stocks logo

FLO

Flowers Foods Inc

$18.89
-2.28%
stocks logo

OGN

Organon & Co

$15.49
-3.97%
stocks logo

NOG

Northern Oil and Gas Inc

$31.99
-0.62%
stocks logo

SRRK

Scholar Rock Holding Corp

$36.48
0.36%
stocks logo

UNF

UniFirst Corp

$211.94
-0.69%
stocks logo

SIM

Grupo Simec SAB de CV

$26.32
0.00%
stocks logo

ACHC

Acadia Healthcare Company Inc

$41.38
-2.29%